Bausch Health completes DURECT acquisition for $63 million
Tweet Send to a Friend
Bausch Health Companies Inc. (NYSE: BHC) completed its acquisition of DURECT Corporation (NASDAQ: DRRX) for $1.75 per share in cash ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE


